Nuvalent, Inc.
Company Information
Industry Pharmaceutical Preparations
SIC Code 2834
Entity Type operating
SEC Category Large accelerated filer
State of Incorporation DE
Business Address ONE BROADWAY, 14TH FLOOR, CAMBRIDGE, MA, 02142
Mailing Address ONE BROADWAY, 14TH FLOOR, CAMBRIDGE, MA, 02142
Phone 508-446-2272
Fiscal Year End 1231
EIN 000000000
Financial Overview
FY2024
-$126.22M
Net Income
$1.14B
Total Assets
$1.07B
Stockholders' Equity
$335.39M
Cash & Equivalents
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| SCHEDULE 13G/A Passive ownership amendment | February 12, 2026 | View on SEC |
| 4 Insider stock transaction report | February 2, 2026 | View on SEC |
| 4 Insider stock transaction report | January 23, 2026 | View on SEC |
| 8-K Current report of material events | January 14, 2026 | View on SEC |
| 4 Insider stock transaction report | January 7, 2026 | View on SEC |
| 4 Insider stock transaction report | January 7, 2026 | View on SEC |
| 4 Insider stock transaction report | January 7, 2026 | View on SEC |
| 4 Insider stock transaction report | January 7, 2026 | View on SEC |
| 4 Insider stock transaction report | January 7, 2026 | View on SEC |
| 4 Insider stock transaction report | January 7, 2026 | View on SEC |
Insider Trading
STRONG SELL 8 insiders
78 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.